GEN Exclusives

More »

GEN News Highlights

Back to Item »

Pfizer’s Inlyta Approved in U.S. as Therapy for Advanced Renal Cell Carcinoma

Kinase inhibitor cleared for treating RCC after failure of one prior systemic therapy.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?